Dekkers Marijn E
SEC-identified person · CIK 1216068 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Cerevel Therapeutics Holdings, Inc. CERF | Director | filed 2020–2024 |
| Soaring Eagle Acquisition Corp. SRNG | Director | filed 2021–2024 |
| Telesis Bio Inc. TBIO | Officer | filed 2023–2023 |
| Quantum-Si Inc QSI | Director | filed 2021–2022 |
| Quanterix Corp QTRX | Director | filed 2017–2021 |
| General Electric CO GE | Director | filed 2012–2018 |
| Thermo Fisher Scientific INC. TMO | Director · Chief Executive Officer | filed 2006–2009 |
| Biogen INC. BIIB | Director | filed 2007–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.